These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18657096)

  • 61. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
    Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
    Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.
    Luo N; Seng BK; Thumboo J; Feeny D; Li SC
    Qual Life Res; 2006 Jun; 15(5):889-98. PubMed ID: 16721648
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of health-related quality of life measures for chronic renal failure: quality of well-being scale, short-form-6D, and the kidney disease quality of life instrument.
    Saban KL; Stroupe KT; Bryant FB; Reda DJ; Browning MM; Hynes DM
    Qual Life Res; 2008 Oct; 17(8):1103-15. PubMed ID: 18791810
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Health state utilities in latent and active tuberculosis.
    Guo N; Marra CA; Marra F; Moadebi S; Elwood RK; Fitzgerald JM
    Value Health; 2008 Dec; 11(7):1154-61. PubMed ID: 18489493
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exploring the consistency of the SF-6D.
    Ferreira LN; Ferreira PL; Pereira LN; Rowen D; Brazier JE
    Value Health; 2013; 16(6):1023-31. PubMed ID: 24041352
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparing 15D and SF-6D performance in fragility wrist and hip fracture patients in a two-year follow-up case-control study.
    Rohde G; Moum T; Haugeberg G
    Value Health; 2012 Dec; 15(8):1100-7. PubMed ID: 23244813
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mapping the SF-12 to preference-based instruments: convergent validity in a low-income, minority population.
    Franks P; Lubetkin EI; Gold MR; Tancredi DJ
    Med Care; 2003 Nov; 41(11):1277-83. PubMed ID: 14583690
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.
    Stavem K; Frøland SS; Hellum KB
    Qual Life Res; 2005 May; 14(4):971-80. PubMed ID: 16041894
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Methodology and measurement properties of health-related quality of life instruments: a prospective study of patients undergoing breast reduction surgery.
    Thoma A; Sprague S; Veltri K; Duku E; Furlong W
    Health Qual Life Outcomes; 2005 Jul; 3():44. PubMed ID: 16042775
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Health-related quality of life in Chilean patients with chronic obstructive pulmonary disease].
    Collado-Mateo D; Adsuar JC; Olivares PR; García-Gordillo MÁ
    Rev Med Chil; 2017 Feb; 145(2):147-155. PubMed ID: 28453580
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mapping the SF-12 to the HUI3 and VAS in a managed care population.
    Sengupta N; Nichol MB; Wu J; Globe D
    Med Care; 2004 Sep; 42(9):927-37. PubMed ID: 15319619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The feasibility and responsiveness of the health utilities index in patients with early-stage breast cancer: a prospective longitudinal study.
    Lovrics PJ; Cornacchi SD; Barnabi F; Whelan T; Goldsmith CH
    Qual Life Res; 2008 Mar; 17(2):333-45. PubMed ID: 18224459
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predicting preference-based SF-6D index scores from the SF-8 health survey.
    Wang P; Fu AZ; Wee HL; Lee J; Tai ES; Thumboo J; Luo N
    Qual Life Res; 2013 Sep; 22(7):1675-83. PubMed ID: 23054496
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Validation of the SF-6D Health State Utilities Measure in Lower Extremity Sarcoma.
    Gundle KR; Cizik AM; Punt SE; Conrad EU; Davidson DJ
    Sarcoma; 2014; 2014():450902. PubMed ID: 24771999
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation and measurement of health-related quality of life for individuals with diabetes mellitus by Health Utilities Index Mark 3 (HUI3) system.
    Mo F; Morrison H; Choi BC; Vardy L
    ScientificWorldJournal; 2006 Nov; 6():1412-23. PubMed ID: 17115081
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Portuguese value set for the SF-6D.
    Ferreira LN; Ferreira PL; Pereira LN; Brazier J; Rowen D
    Value Health; 2010 Aug; 13(5):624-30. PubMed ID: 20230545
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exploring psychometric properties of the SF-6D, a preference-based health-related quality of life measure, in the context of spinal cord injury.
    Engel L; Bryan S; Evers SM; Dirksen CD; Noonan VK; Whitehurst DG
    Qual Life Res; 2014 Oct; 23(8):2383-93. PubMed ID: 24700379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence.
    Pinto AM; Subak LL; Nakagawa S; Vittinghoff E; Wing RR; Kusek JW; Herman WH; West DS; Kuppermann M
    Qual Life Res; 2012 Dec; 21(10):1685-94. PubMed ID: 22161726
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparison of the quality of life of hearing-impaired people as estimated by three different utility measures.
    Barton GR; Bankart J; Davis AC
    Int J Audiol; 2005 Mar; 44(3):157-63. PubMed ID: 15916116
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis.
    Marrie RA; Dolovich C; Cutter GR; Fox RJ; Salter A
    Front Neurol; 2021; 12():747853. PubMed ID: 34975716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.